Childhood MMR vaccine – which protects against measles, mumps and rubella – will now become a combined MMRV to also build immunity against the chickenpox virus
A vaccine against chickenpox is being rolled out on the NHS for the first time from today.
It will be added to the UK child vaccination programme as part of the MMR jab, which protects against measles, mumps and rubella. Chickenpox is caused by the varicella zoster virus and mostly affects children but can be caught at any age. It causes a mild illness which most children can recover from at home but in a small percentage can lead to serious complications and even death.
Health Secretary Wes Streeting said: “Today marks a historic milestone in protecting our children’s health. For the first time the NHS is offering chickenpox vaccination as part of our routine childhood immunisation programme.
READ MORE: NHS chickenpox vaccine for children announcement – what it all means
“Many families have faced the threat of chickenpox, which can cause serious complications. The disease also brings significant worry and disruption, with children missing nursery or school and parents forced to stay home to look after them.
“This new protection will give parents reassurance that their children are protected from a disease that sends thousands to hospital every year.”
The NHS announcement confirms the UK and devolved governments have accepted the recommendation of the Joint Committee on Vaccination and Immunisation (JCVI) from 2023.
The rollout across the four nations of the UK will see hundreds of thousands of children become eligible for the jab from Friday. GPs will be contacting families to offer the new combined MMRV vaccine as part of the routine childhood vaccination programme.
Dr Gayatri Amirthalingam, deputy director of immunisation at the UK Health Security Agency, said: “Most parents probably consider chickenpox to be a common and mild illness, but for some babies, young children and even adults, chickenpox can be very serious, leading to hospital admission and tragically, while rare, it can be fatal.
“This vaccine has been used extensively for many years in a number of countries and has been shown to be highly effective with a good safety profile. The programme will have a really positive impact on the health of young children.”
The combined MMRV jab has been used in other countries for decades and is part of routine childhood vaccines in the US, Canada, Australia and Germany.
In rare cases chickenpox complications can include bacterial infections such as group A streptococcus, a swelling of the brain called encephalitis, inflammation of the lungs called pneumonitis, and strokes. Very young infants under four weeks of age are more likely to experience serious illness, as are adults.
Until now parents concerned about chickenpox had to pay privately for their child to be vaccinated at a cost of around £150.
The NHS only offered the jab for children in close contact with someone at risk of getting seriously ill if they catch it, such as a parent with cancer.
NHS England said children born on or after January 1 2025 will be offered two doses of the MMRV vaccine at 12 months and 18 months, while children born between July 1 2024 and December 31 2024 will be offered two doses at 18 months and three years and four months.
Children born between September 1 2022 and June 30 2024 will be offered one dose at three years and four months, and the NHS is also planning a single-dose catch-up programme later in the year for children born between January 1 2020 and August 31 2022.
Professor Steven Turner, president of the Royal College of Paediatrics and Child Health, said: “It is welcome news that a chickenpox vaccine is now being rolled out across England and the whole of the UK in order to protect children and young people.
“Vaccinations are proven to be a very effective way to protect children’s health and prevent serious illness. Making sure your child is vaccinated is a vital step for parents and carers in keeping them safe.”
